Pressmeddelande

Calmark streamlines the organization to increase the focus on sales of the company's fully developed products

Cision Publicerad: 28 Nov 2022 09:45

Calmark Sweden AB (publ) announced today that the company has initiated measures to streamline the internal organization and to prioritize the sales of the company's fully developed products. The development projects for new biomarkers are paused until further notice and the organization is thus reduced by 25%. The ambition is for Calmark to become cash flow positive in the coming year.

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

This disclosure contains information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 28-11-2022 09:45 CET.

Bifogade filer

Releasehttps://mb.cision.com/Main/17252/3673754/1698023.pdf

Nyheter om Calmark

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!